• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝脏脂蛋白脂肪酶:覆盖催化位点的环介导脂肪酶底物特异性。

Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity.

作者信息

Dugi K A, Dichek H L, Santamarina-Fojo S

机构信息

Molecular Disease Branch, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Biol Chem. 1995 Oct 27;270(43):25396-401. doi: 10.1074/jbc.270.43.25396.

DOI:10.1074/jbc.270.43.25396
PMID:7592706
Abstract

Hepatic lipase (HL) and lipoprotein lipase (LPL) are key enzymes that mediate the hydrolysis of triglycerides (TG) and phospholipids (PL) present in circulating plasma lipoproteins. Relative to triacylglycerol hydrolysis, HL displays higher phospholipase activity than LPL. The structural basis for this difference in substrate specificity has not been definitively established. We recently demonstrated that the 22-amino acid loops ("lids") covering the catalytic sites of LPL and HL are critical for the interaction with lipid substrate (Dugi, K.A., Dichek, H.L., Talley, G.D., Brewer, H.B., Jr., and Santamarina-Fojo, S. (1992) J. Biol. Chem. 267, 25086-25091). To determine whether the lipase lid plays a role in conferring the different substrate specificities of HL and LPL, we have generated four chimeric lipases. Characterization of these chimeric enzymes using TG (triolein and tributyrin) or PL (dioleoylphosphatidylcholine (DOPC) vesicles, DOPC proteoliposomes, and DOPC-mixed liposomes) substrates demonstrated marked differences between their relative PL/TG hydrolyzing activities. Chimeric LPL containing the lid of HL had reduced triolein hydrolyzing activity (49% of the wild type), but increased phospholipase activity in DOPC vesicle, DOPC proteoliposome, and DOPC-mixed liposome assay systems (443, 628, and 327% of wild-type LPL, respectively). In contrast, chimeric HL containing the LPL lid was more active against triolein (123% of the wild type) and less active against DOPC (23, 0, and 30%, respectively) than normal HL. Similar results were obtained when the lipase lids were exchanged in chimeric enzymes containing the NH2-terminal end of LPL and the COOH-terminal domain of HL. Exchange of the LPL and HL lids resulted in a reversal of the phospholipase/neutral lipase ratio, establishing the important role of this region in mediating substrate specificity. In summary, the lid covering the catalytic domains in LPL and HL plays a crucial role in determining lipase substrate specificity. The lid of LPL confers preferential triglyceride hydrolysis, whereas the lid of HL augments phospholipase activity. This study provides new insight into the structural basis for the observed in vivo differences in LPL and HL function.

摘要

肝脂酶(HL)和脂蛋白脂肪酶(LPL)是介导循环血浆脂蛋白中甘油三酯(TG)和磷脂(PL)水解的关键酶。相对于甘油三酯水解,HL比LPL表现出更高的磷脂酶活性。这种底物特异性差异的结构基础尚未明确确立。我们最近证明,覆盖LPL和HL催化位点的22个氨基酸环(“盖子”)对于与脂质底物的相互作用至关重要(Dugi,K.A.,Dichek,H.L.,Talley,G.D.,Brewer,H.B.,Jr.,和Santamarina-Fojo,S.(1992年)《生物化学杂志》267,25086 - 25091)。为了确定脂肪酶盖子是否在赋予HL和LPL不同底物特异性方面发挥作用,我们构建了四种嵌合脂肪酶。使用TG(三油精和三丁酸甘油酯)或PL(二油酰磷脂酰胆碱(DOPC)囊泡、DOPC蛋白脂质体和DOPC混合脂质体)底物对这些嵌合酶进行表征,结果表明它们相对的PL/TG水解活性存在显著差异。含有HL盖子的嵌合LPL的三油精水解活性降低(为野生型的49%),但在DOPC囊泡、DOPC蛋白脂质体和DOPC混合脂质体测定系统中的磷脂酶活性增加(分别为野生型LPL的443%、628%和327%)。相反,含有LPL盖子的嵌合HL对三油精的活性更高(为野生型的123%),而对DOPC的活性低于正常HL(分别为23%、0%和30%)。当在含有LPL氨基末端和HL羧基末端结构域的嵌合酶中交换脂肪酶盖子时,也获得了类似的结果。LPL和HL盖子的交换导致磷脂酶/中性脂肪酶比率发生逆转,确立了该区域在介导底物特异性方面的重要作用。总之,覆盖LPL和HL催化结构域的盖子在决定脂肪酶底物特异性方面起着关键作用。LPL的盖子赋予优先的甘油三酯水解能力,而HL的盖子增强磷脂酶活性。这项研究为观察到的LPL和HL在体内功能差异的结构基础提供了新的见解。

相似文献

1
Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity.人肝脏脂蛋白脂肪酶:覆盖催化位点的环介导脂肪酶底物特异性。
J Biol Chem. 1995 Oct 27;270(43):25396-401. doi: 10.1074/jbc.270.43.25396.
2
Analysis of protein structure-function in vivo. Adenovirus-mediated transfer of lipase lid mutants in hepatic lipase-deficient mice.体内蛋白质结构功能分析。腺病毒介导的脂肪酶盖突变体在肝脂肪酶缺陷小鼠中的转移。
J Biol Chem. 1996 Oct 18;271(42):26296-301.
3
Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties.肝脂肪酶与脂蛋白脂肪酶的嵌合体。酶特异性性质的结构域定位。
J Biol Chem. 1992 Oct 25;267(30):21499-504.
4
Functional characterization of a chimeric lipase genetically engineered from human lipoprotein lipase and human hepatic lipase.一种由人脂蛋白脂肪酶和人肝脂肪酶基因工程改造而成的嵌合脂肪酶的功能特性
J Lipid Res. 1993 Aug;34(8):1393-40.
5
Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability.脂蛋白脂肪酶(LPL415;-438)中对底物相互作用和二聚体稳定性至关重要的新位点。
J Lipid Res. 2001 Aug;42(8):1180-6.
6
Human lipoprotein lipase: the loop covering the catalytic site is essential for interaction with lipid substrates.人脂蛋白脂肪酶:覆盖催化位点的环对于与脂质底物的相互作用至关重要。
J Biol Chem. 1992 Dec 15;267(35):25086-91.
7
Substrate specificity of lipoprotein lipase and endothelial lipase: studies of lid chimeras.脂蛋白脂肪酶和内皮脂肪酶的底物特异性:盖氏嵌合体研究
J Lipid Res. 2006 Aug;47(8):1803-11. doi: 10.1194/jlr.M500552-JLR200. Epub 2006 May 8.
8
Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase.通过化学交联以及将载脂蛋白C-II反应性脂解作用从脂蛋白脂肪酶转移至肝脂肪酶来鉴定脂蛋白脂肪酶辅因子结合位点。
J Biol Chem. 2003 Jun 20;278(25):23027-35. doi: 10.1074/jbc.M300315200. Epub 2003 Apr 7.
9
Structural basis of endothelial lipase tropism for HDL.内皮脂肪酶对高密度脂蛋白(HDL)趋向性的结构基础。
FASEB J. 2004 Dec;18(15):1891-3. doi: 10.1096/fj.03-1307fje. Epub 2004 Sep 28.
10
Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding.肝脂肪酶和脂蛋白脂肪酶的亚结构域嵌合体。肝素和辅因子结合的定位
J Biol Chem. 1998 Nov 20;273(47):30979-84. doi: 10.1074/jbc.273.47.30979.

引用本文的文献

1
How to Reproduce in the Siberian Winter: Proteome Dynamics Reveals the Timing of Reproduction-Related Processes in an Amphipod Species Endemic to Lake Baikal.如何在西伯利亚冬季进行繁殖:蛋白质组动力学揭示了贝加尔湖特有一种桡足类动物与繁殖相关过程的时间安排。
Ecol Evol. 2025 Jul 23;15(7):e71675. doi: 10.1002/ece3.71675. eCollection 2025 Jul.
2
Macromolecular Interactions of Lipoprotein Lipase (LPL).脂蛋白脂肪酶(LPL)的大分子相互作用。
Subcell Biochem. 2024;104:139-179. doi: 10.1007/978-3-031-58843-3_8.
3
Loss-of-Function Homozygous Variant in Causes Type I Hyperlipoproteinemia and Renal Lipidosis.
[基因名称]功能缺失型纯合变异导致I型高脂蛋白血症和肾脂质沉积症。
Kidney Int Rep. 2023 Aug 25;8(11):2428-2438. doi: 10.1016/j.ekir.2023.08.027. eCollection 2023 Nov.
4
Enhancing the Hydrolytic Activity of a Lipase towards Larger Triglycerides through Lid Domain Engineering.通过盖域工程提高脂肪酶对较大三酰基甘油的水解活性。
Int J Mol Sci. 2023 Sep 6;24(18):13768. doi: 10.3390/ijms241813768.
5
Phase-Separated Liposomes Hijack Endogenous Lipoprotein Transport and Metabolism Pathways to Target Subsets of Endothelial Cells In Vivo.相分离脂质体劫持内源性脂蛋白转运和代谢途径,以靶向体内内皮细胞的亚群。
Adv Healthc Mater. 2023 Apr;12(10):e2202709. doi: 10.1002/adhm.202202709. Epub 2023 Jan 19.
6
Identification of a Gain-of-Function Variant as a Novel Cause of Familial Combined Hypocholesterolemia.鉴定一种功能获得性变异为家族性混合型高脂血症的新病因。
Circulation. 2022 Sep 6;146(10):724-739. doi: 10.1161/CIRCULATIONAHA.121.057978. Epub 2022 Jul 28.
7
Lyso-Lipid-Induced Oligodendrocyte Maturation Underlies Restoration of Optic Nerve Function.溶血磷脂诱导少突胶质细胞成熟是视神经功能恢复的基础。
eNeuro. 2022 Jan 26;9(1). doi: 10.1523/ENEURO.0429-21.2022. Print 2022 Jan-Feb.
8
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis.脂蛋白脂肪酶调节在动脉粥样硬化中的重要性。
Biomedicines. 2021 Jul 6;9(7):782. doi: 10.3390/biomedicines9070782.
9
Digenic Inheritance and Gene-Environment Interaction in a Patient With Hypertriglyceridemia and Acute Pancreatitis.一名高甘油三酯血症和急性胰腺炎患者的双基因遗传与基因-环境相互作用
Front Genet. 2021 Apr 16;12:640859. doi: 10.3389/fgene.2021.640859. eCollection 2021.
10
Lipoprotein Profiles before Heparin Administration in Patients with or without Coronary Thrombosis Following Atherosclerosis.动脉粥样硬化后有或无冠状动脉血栓形成患者在给予肝素前的脂蛋白谱。
Ann Vasc Dis. 2021 Mar 25;14(1):31-38. doi: 10.3400/avd.oa.20-00146.